KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 85 filers reported holding KALA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 7.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -75.0% | 8,448 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $12,000 | -45.5% | 8,448 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $22,000 | -51.1% | 8,448 | 0.0% | 0.00% | -60.0% |
| Q2 2021 | $45,000 | -21.1% | 8,448 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $57,000 | 0.0% | 8,448 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $57,000 | -9.5% | 8,448 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $63,000 | -29.2% | 8,448 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $89,000 | +20.3% | 8,448 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $74,000 | – | 8,448 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |